Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-007913
Filing Date
2024-10-28
Accepted
2024-10-28 16:37:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5789
  Complete submission text file 0001950047-24-007913.txt   7264
Mailing Address C/O SANGAMO BIOSCIENCES, INC STE-A-100 POINT RICHMOND TECH, 501 CANAL BLVD, RICHMOND CA 94804
Business Address
ZANTE GREG (Reporting) CIK: 0001264949 (see all company filings)

Type: 144

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37355 | Film No.: 241401397
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)